EP Patent

EP3768321A4 — ORAL FORMULATIONS OF METRONIDAZOLE AND METHODS OF TREATING INFECTION USING THE SAME

Assigned to Appili Therapeutics Inc · Expires 2022-05-04 · 4y expired

What this patent protects

Patent listed against Metro I.V. In Plastic Container.

Drugs covered by this patent

Metro I.V. In Plastic Container (METRONIDAZOLE) · Baxter

Patent Metadata

Patent number: EP3768321A4
Jurisdiction: EP
Classification: —
Expires: 2022-05-04
Drug substance claim: No
Drug product claim: No
Assignee: Appili Therapeutics Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.